Abstract

ObjectiveThe aim of this study is to assess the performance of a computer-aided semi-automated algorithm we have adapted for the purpose of segmenting malignant pleural mesothelioma (MPM) on CT.MethodsForty-five CT scans were collected from 15 patients (M:F = 10:5, mean age 62.8 years) in a multi-centre clinical drug trial. A computer-aided random walk-based algorithm was applied to segment the tumour; the results were then compared to radiologist-drawn contours and correlated with measurements made using the MPM-adapted Response Evaluation Criteria in Solid Tumour (modified RECIST).ResultsA mean accuracy (Sørensen–Dice index) of 0.825 (95% CI [0.758, 0.892]) was achieved. Compared to a median measurement time of 68.1 min (range [40.2, 102.4]) for manual delineation, the median running time of our algorithm was 23.1 min (range [10.9, 37.0]). A linear correlation (Pearson’s correlation coefficient: 0.6392, p < 0.05) was established between the changes in modified RECIST and computed tumour volume.ConclusionVolumetric tumour segmentation offers a potential solution to the challenges in quantifying MPM. Computer-assisted methods such as the one presented in this study facilitate this in an accurate and time-efficient manner and provide additional morphological information about the tumour’s evolution over time.

Highlights

  • Malignant pleural mesothelioma (MPM) is an aggressive thoracic malignancy that is closely linked to past exposure to asbestos

  • We present a computer-aided segmentation algorithm that is capable of accurately segmenting the MPM tumour and has the ability to incorporate input from end-users with good robustness

  • The data used in this study were collected from a Phase II clinical trial of Vinflunine, which was tested as a therapeutic agent for MPM across nine centres in the UK, France, and Germany

Read more

Summary

Introduction

Malignant pleural mesothelioma (MPM) is an aggressive thoracic malignancy that is closely linked to past exposure to asbestos. It is currently responsible for over 47,000 annual deaths worldwide, a number which continues to increase despite legal restrictions limiting the use of asbestos in many countries [1]. Their overlapping nature, the tumour’s low contrast on CT, is evident

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call